Collegium Pharmaceutical Inc (COLL)
Operating Income Growth
-89.47%
Quarterly · Period ending:
COLL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-89.47%period ending
Latest reported-89.47%period ending
COLL Quarterly Operating Income YoY % (3.04% → -89.47%)
Year-over-year change
High-resolution chart · PNG
COLL operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -89.4659% | |
| 47.3924% | |
| 55.3987% | |
| 82.6114% | |
| -26.0496% | |
| -56.1649% | |
| -38.2198% | |
| -22.6024% | |
| 33.222% | |
| 100.8933% | |
| 424.6917% | |
| 119.9296% | |
| 220.7291% | |
| 345.9011% | |
| 134.4558% | |
| 44.6533% | |
| -32.2933% | |
| -147.2584% | |
| -327.5407% | |
| -27.9069% | |
| -0.846% | |
| 318.7315% | |
| 731.9427% | |
| 407.8588% | |
| 430.4513% | |
| 150.6505% | |
| -121.5708% | |
| 43.0091% | |
| 31.3314% | |
| 24.3432% | |
| 162.5661% | |
| 16.7089% | |
| 65.6929% | |
| 43.0143% | |
| 36.245% | |
| 49.2096% | |
| 13.1405% | |
| -48.688% | |
| -192.2743% | |
| -185.3967% | |
| -434.9508% | |
| -329.3939% | |
| -183.6189% | |
| -42.4289% | |
| -11.9129% | |
| 3.0449% |